ADC Therapeutics SA
ADCT
$3.54
-$0.41-10.38%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.68% | -46.74% | -25.63% | 30.12% | -20.32% |
| Total Depreciation and Amortization | -85.48% | 4.87% | 1.01% | -1.12% | -4.30% |
| Total Amortization of Deferred Charges | 12.77% | 240.31% | 134.29% | -207.95% | 17.27% |
| Total Other Non-Cash Items | -35.83% | 45.70% | 877.45% | -115.31% | 25.23% |
| Change in Net Operating Assets | -97.45% | 152.00% | -394.36% | 17.40% | 277.24% |
| Cash from Operations | -23.01% | 57.24% | -157.80% | 12.74% | 23.75% |
| Capital Expenditure | -- | 100.00% | -193.33% | 58.33% | -620.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -193.33% | 58.33% | -620.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 34,598.52% | 530.23% | -- | -- |
| Repurchase of Common Stock | 20.80% | -- | -- | -32.31% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.21% | 34,506.27% | 124.20% | -27.42% | -100.89% |
| Foreign Exchange rate Adjustments | -96.32% | 1.24% | 146.94% | -217.87% | 2,325.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -142.69% | 224.38% | -139.97% | 9.45% | -139.26% |